Perspective

 
 

  • Key Data in Non-Hodgkin Lymphoma From EHA 2023   Key data in non-Hodgkin lymphoma from EHA 2023 include evidence for omitting radiotherapy, findings of no benefit of IV over IT methotrexate in CNS prophylaxis, and two positive CAR T-cell studies.
  • Medscape Medical Minute   Dr Perry Wilson highlights the day's top news stories, produced by Medscape, the leading source of information for medical professionals. From new clinical evidence to breaking policy news, stay on the pulse of medicine with Medscape Medical Minute.
  • A Glimmer of an Answer to Long COVID Long COVID has been little more than a laundry list of vague symptoms, including shortness of breath, fatigue, fever, headaches, "brain fog," and a variety of other neurologic problems.
  • Who Benefits From Continuous Glucose Monitoring? Will continuous glucose monitoring add to healthcare professionals' workload and worsen diabetes distress in patients with type 2 diabetes?
  • ECG Challenge: AF Patient With Lightheadedness, Rapid Pulse A 73-year-old man with atrial fibrillation feels lightheaded and has a rapid pulse. What's going on?
  • Affirmative Action Overturned: A Physician Laments The Supreme Court ruling against affirmative action is a sad occasion for this cardiologist who grew up in the segregated South.
  • Clinical Updates in Myelofibrosis From EHA 2023   Novel strategies in ruxolitinib-refractory patients, use of BET inhibitors plus JAK inhibitors to deepen response, and luspatercept to tackle anemia are covered in myelofibrosis updates from EHA 2023.
  • 3 Years Into Long COVID: Where Do We Go From Here? In April 2021, after 13 months of having long COVID and helping conduct two patient-led research studies on the condition, I testified to Congress about what was needed to address the crisis.
  • Highlights on Thrombosis and Hemostasis From EHA 2023   Thrombosis and hemostasis highlights from EHA 2023 identify VTE as a major complication in acute promyelocytic leukemia, biomarkers for VTE in lung cancer, and an investigational thrombosis inhibitor.
  • Bempedoic Acid: A Statin-Intolerance Savior? Associated with positive cardiovascular outcomes in a mixed cardiovascular risk population, bempedoic is an evidenced-based alternative for statin-intolerant patients.
  • At ASCO, the Cancer Community Hyped the Wrong Trial Oncologist Bishal Gyawali, MD, PhD, highlights concerns surrounding which trials the oncology community is choosing to celebrate.
  • Infographic: Vacation Destinations to Recharge Your Batteries Physicians can find what they and their families need for much-deserved summer relaxation in this list of US destinations for all preferences and personalities.
  • Episode 2: Evolving Research in the Field of Chronic Myeloid Leukemia   Drs Michael J. Mauro and Ehab Atallah discuss current chronic myeloid leukemia research, where the US stands in comparison with the world, and the important work being conducted by the Cure CML Consortium.
  • Episode 1: Chronic Myeloid Leukemia Therapy and the Mark Cuban Effect   Drs Michael J. Mauro and Hagop Kantarjian discuss the cost of chronic myeloid leukemia therapy, long-term safety, adverse events, and the financial toxicity to the patient and the healthcare system.
  • Tirzepatide: Therapeutic Titan or Costly Cure? Tirzepatide has been boldly positioned as a third-generation obesity medication. But what is its role in primary care, and more important, can we afford it?
  • From Physician to Patient to Reinventing Medicine   Bob Harrington interviews Jag Singh about the COVID journey that led to his book, "Future Care: Sensors, Artificial Intelligence, and the Reinvention of Medicine."
  • Can a Healthy Gut Help Solve the Obesity Epidemic? Products claiming to create a healthy gut microbiome proliferate the mainstream. Are there health benefits to such supplements? And what is the relationship between the gut microbiome and obesity?
  • Lessons From Stanford: How to Make the Future More Female Stanford's general surgery resident class is almost entirely female. Other schools should use their achievement as a model.
  • Beta Cells From Stem Cells: Nearing a Cure for Type 1 Diabetes?   Anne L. Peters, MD, discusses clinical trial results of beta cells made from stem cells in patients with type 1 diabetes.
  • Endocrine Therapy Plus Targeted Agents in MBC Endocrine therapy remains the mainstay of treatment in metastatic breast cancer. Dr Erica Mayer discusses adding targeted agents as clinicians strive to improve therapeutic options and efficacy.